Chiyang Li
No.253. Gongye Middle Avenue, Haizhu District, 510280
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Posttranslational Oxidation of SOD1 and Skin Aging: Evidence, Gaps, and Future Directions.
Journal: Ageing research reviews
Published: July 06, 2026
A multi-scale framework to advance experimental models of skin aging.
Journal: Experimental gerontology
Published: May 15, 2026
Adipose-derived mesenchymal stem cell exosomes enhance diabetic wound healing via the amelioration of fibroblast senescence through the SMARCAL1-Drp1 signaling pathway.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 19, 2025
LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation.
Journal: Cancer cell international
Published: August 14, 2024
Correction: SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma.
Journal: Cell death & disease
Published: July 11, 2023
The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 28, 2022
Correction: SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma.
Journal: Cell death & disease
Published: December 12, 2022
A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM.
Journal: Frontiers in oncology
Published: August 21, 2022
RBBP4 regulates the expression of the Mre11-Rad50-NBS1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance.
Journal: Cancer letters
Published: August 16, 2022
SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma.
Journal: Cell death & disease
Published: July 08, 2022
SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
Journal: Molecular medicine reports
Published: July 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026